Which choice best describes the purpose of most pharmacogenomic research?

The answer

The choice that best describes the purpose of most pharmacogenomic research is: to understand how an individual's genetic variations influence their response to drugs, so medications can be chosen and dosed to be safer and more effective for each patient. The word itself is the clue - pharmaco (drugs) + genomics (the study of genes) - the study of how genes shape drug response.

People differ in genes that code for the enzymes, transporters, and receptors that process medications. Because of these differences, the same drug at the same dose can be perfectly effective for one person, useless for another, and dangerously toxic for a third. The goal of pharmacogenomic research is to map these gene-drug relationships so clinicians can move away from one-size-fits-all prescribing and toward precision (personalized) medicine - the right drug, at the right dose, for the right patient.

How genes change drug response

Many drugs are metabolized by liver enzymes such as the cytochrome P450 family. A genetic variant can make someone a poor metabolizer (the drug builds up, raising the risk of side effects) or an ultra-rapid metabolizer (the drug is cleared too fast to work). Two well-known examples:

• Warfarin, a blood thinner: variants in the CYP2C9 and VKORC1 genes strongly affect the dose a patient needs. Testing helps avoid dangerous over- or under-anticoagulation.
• Codeine: it must be converted by the CYP2D6 enzyme into morphine to relieve pain. Ultra-rapid metabolizers can convert too much and suffer toxicity, while poor metabolizers get little pain relief.

These examples show the core purpose in action: use the patient's genotype to predict drug response and adjust therapy.

Why the other options are wrong

Typical distractors describe related but different goals:

• "To discover entirely new diseases." That is not the aim. Pharmacogenomics studies drug response, not the discovery of new illnesses.
• "To create a single drug that works the same for everyone." This is the opposite of the field's purpose. Pharmacogenomics exists precisely because people respond differently; it individualizes therapy rather than standardizing it.
• "To clone genes" or "to edit a patient's DNA." Pharmacogenomic research analyzes existing genetic variation to guide prescribing; it is not gene therapy or genetic engineering.
• "To lower the overall cost of manufacturing drugs." Reducing adverse reactions can save money, but cost reduction is a downstream benefit, not the defining purpose.

The bigger picture

Pharmacogenomics is a cornerstone of precision medicine. By predicting who will benefit from a drug and who is at risk of harm, it reduces trial-and-error prescribing, prevents adverse drug reactions, and improves outcomes. Note the subtle distinction from pharmacogenetics, which usually looks at one or a few genes affecting one drug; pharmacogenomics takes the broader, genome-wide view - though the terms are often used interchangeably.